Victory Capital Management Inc Vista Gen Therapeutics, Inc. Transaction History

Victory Capital Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$0.12 - $0.3 $2,919 - $7,298	24,328 New	24,328 $2,000
Q4 2021 Feb 07, 2022	SELL	$1.67 - $2.76 $1.33 Million - $2.2 Million	-795,720 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$2.62 - $3.45 $906,310 - $1.19 Million	345,920 Added 76.91%	795,720 $2.18 Million
Q2 2021 Aug 03, 2021	BUY	$1.96 - $3.15 $219,559 - $352,863	112,020 Added 33.16%	449,800 $1.42 Million
Q1 2021 May 04, 2021	BUY	$1.89 - $2.96 $638,404 - $999,828	337,780 New	337,780 $719,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.